CORD-19:775b90287b44353bee979abb0970a4666022f86d / 630367-630611 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T22012","span":{"begin":0,"end":244},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In patients with PI who were treated with IGHy for up to 3 years, infection rates were low and AE rates were comparable to previously reported rates for patients treated with IGSC, but with infusion volumes and rates equivalent to that of IGIV."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T424","span":{"begin":0,"end":244},"obj":"Sentence"}],"text":"In patients with PI who were treated with IGHy for up to 3 years, infection rates were low and AE rates were comparable to previously reported rates for patients treated with IGSC, but with infusion volumes and rates equivalent to that of IGIV."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4870","span":{"begin":66,"end":75},"obj":"Disease"},{"id":"T4871","span":{"begin":95,"end":97},"obj":"Disease"},{"id":"T66812","span":{"begin":66,"end":75},"obj":"Disease"},{"id":"T32988","span":{"begin":95,"end":97},"obj":"Disease"}],"attributes":[{"id":"A4870","pred":"mondo_id","subj":"T4870","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A4871","pred":"mondo_id","subj":"T4871","obj":"http://purl.obolibrary.org/obo/MONDO_0010481"},{"id":"A55272","pred":"mondo_id","subj":"T66812","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A38376","pred":"mondo_id","subj":"T32988","obj":"http://purl.obolibrary.org/obo/MONDO_0010481"}],"text":"In patients with PI who were treated with IGHy for up to 3 years, infection rates were low and AE rates were comparable to previously reported rates for patients treated with IGSC, but with infusion volumes and rates equivalent to that of IGIV."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T3431","span":{"begin":95,"end":97},"obj":"Phenotype"}],"attributes":[{"id":"A3431","pred":"hp_id","subj":"T3431","obj":"http://purl.obolibrary.org/obo/HP_0100665"}],"text":"In patients with PI who were treated with IGHy for up to 3 years, infection rates were low and AE rates were comparable to previously reported rates for patients treated with IGSC, but with infusion volumes and rates equivalent to that of IGIV."}